In the current edition two, we have updated the content according to the recent advances in ophthalmic investigations and imaging, along with the emergence of recent serological tests for Myelin oligodendrocyte glycoprotein (MOG) antibody disease (MOGAD) and Neuromyelitis optica (NMO) disease. We also have also provided high-yield summary points after each case for takeaway messages.